Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,773
Recruiting: 1,496
Ph III recruiting: 183
Growth YoY: +7.3%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,526)

clinicaltrialsPublishedShowing 1–21 of 21 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07761351	A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy(ENCOMPASS)	recruiting	Phase 4	550	Intuitive SurgicalINDUSTRY	3	Sep 25, 2026	clinicaltrials
NCT03340506	Dabrafenib and/or Trametinib Rollover Study	recruiting	Phase 4	100	Novartis PharmaceuticalsINDUSTRY	14	Sep 23, 2026	clinicaltrials